Can two existing drugs stop rheumatic fever from scarring young hearts?
Disease control
Not yet recruiting
Researchers are running a Phase 3 trial to see whether hydroxychloroquine or corticosteroids can reduce heart valve damage in children and young people with acute rheumatic fever. The trial enrolls about 600 participants aged 4 to 25 who are hospitalized with confirmed valve infl…
Phase 3 • Sponsor: Starship Child Health, Te Toka Tumai Auckland • Aim: Disease control
Last updated Sep 21, 2026 23:00 UTC